House of Lords Business
Show full summary

Lord Hunt of Kings Heath to ask Her Majesty's Government, in the light of their response to the report by the House of Commons Defence Select Committee, The use of Lariam for military personnel (4th Report, Session 2015–16), whether they have now ensured that “all anti-malaria drugs are only supplied after a face-to-face travel health risk assessment performed by an appropriately trained and regulated healthcare professional”; and if not, when they expect to achieve 100 per cent compliance with that target.  HL3217

Question HL3217: tabled on 14 November 2017 and due for answer by 28 November 2017

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Hunt of Kings Heath to ask Her Majesty's Government, in the light of their response to the report by the House of Commons Defence Select Committee, The use of Lariam for military personnel (4th Report, Session 2015–16), whether they have now ensured that “all anti-malaria drugs are only supplied after a face-to-face travel health risk assessment performed by an appropriately trained and regulated healthcare professional”; and if not, when they expect to achieve 100 per cent compliance with that target.  HL3217
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Hunt of Kings Heath
Labour
Life peer